Image-based metric of invasiveness predicts response to adjuvant temozolomide for primary glioblastoma.
Massey SC, White H, Whitmire P, Doyle T, Johnston SK, Singleton KW, Jackson PR, Hawkins-Daarud A, Bendok BR, Porter AB, Vora S, Sarkaria JN, Hu LS, Mrugala MM, Swanson KR.
Massey SC, et al.
PLoS One. 2020 Mar 27;15(3):e0230492. doi: 10.1371/journal.pone.0230492. eCollection 2020.
PLoS One. 2020.
PMID: 32218600
Free PMC article.
Clinical Trial.